Guanyun Wang Selected Research

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)

2/2024	The role of 18F-FDG PET/CT metabolic parameters in the differential diagnosis of post-transplant lymphoproliferative disorder after pediatric liver transplantation.
1/2024	Potential Added Value of 18F-FDG PET Metabolic Parameters in Predicting Disease Relapse in Type 1 Autoimmune Pancreatitis.
1/2024	Preoperative metabolic parameters of 18F-FDG PET/CT are associated with TNM stage and prognosis of colorectal cancer patients.
11/2023	Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
9/2023	Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment 18F-FDG PET/CT of Primary Lesions for Pediatric Patients with Neuroblastoma.
9/2023	Multiparameter diagnostic model based on 18F-FDG positron emission tomography and serological examination for differentiating focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
9/2023	The baseline metabolism parameters of 18F‑FDG PET/CT as promising prognostic biomarkers in pediatric Langerhans cell histiocytosis.
2/2023	Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis.
8/2022	Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas.
1/2022	The Combination of 18F-Fluorodeoxyglucose Positron Emission Tomography Metabolic and Clinical Parameters Can Effectively Distinguish Rheumatoid Arthritis and Polymyalgia Rheumatic.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guanyun Wang Research Topics

Disease

6	Neoplasms (Cancer) 01/2024 - 08/2022
2	Autoimmune Pancreatitis 01/2024 - 09/2023
2	Adenocarcinoma 01/2024 - 09/2023
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2024
2	Fever (Fevers) 07/2023 - 02/2023
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2024
1	Lymphadenopathy 02/2024
1	Lymphatic Metastasis 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Neuroblastoma 09/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2023
1	Tuberculosis (Tuberculoses) 07/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2023
1	Neurolymphomatosis 05/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 02/2023
1	Cholecystitis 02/2023
1	Cholecystolithiasis 02/2023
1	Acute Coronary Syndrome 12/2022
1	Lymphoma (Lymphomas) 08/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Amyloidosis 01/2022
1	Hemorrhage 01/2021
1	Neoplasms, Cystic, Mucinous, and Serous 01/2021
1	Atrial Fibrillation 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2020

Drug/Important Bio-Agent (IBA)

12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024 - 12/2020
2	AntigensIBA 01/2024 - 01/2024
2	CarbohydratesIBA 01/2024 - 01/2024
2	Carcinoembryonic AntigenIBA 01/2024 - 01/2024
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2023
2	Chimeric Antigen ReceptorsIBA 07/2023 - 05/2023
2	lenvatinibIBA 01/2023 - 01/2022
1	Immunoglobulin G (IgG)IBA 01/2024
1	Phosphopyruvate Hydratase (Enolase)IBA 09/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Clopidogrel (Plavix)FDA Link 12/2022
1	Amyloidogenic ProteinsIBA 01/2022
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	thioflavin TIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021

Therapy/Procedure

4	Therapeutics 07/2023 - 01/2022
1	Liver Transplantation 02/2024
1	Nephrectomy 12/2020